{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:43:59Z","timestamp":1726245839906},"reference-count":17,"publisher":"Digital Journal of Opthalmology","issue":"3","license":[{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digit J Ophthalmol"],"abstract":"<jats:p>Uveal melanoma size is a significant predictor of tumor metastasis. Although the relationship between antivascular endothelial growth factors (VEGF) and uveal melanoma growth has been studied, results are paradoxical, and the relationship remains controversial. We report the case of a 65-year-old man who presented with elevated intraocular pressure in his right eye, neovascularization of his iris, and significant corneal edema, which obscured the view of the angle. Given his history of proliferative diabetic retinopathy, he was diagnosed with neovascular glaucoma and subsequently received an intravitreal injection of bevacizumab and underwent Ahmed valve insertion. This was complicated by postoperative hyphema. Two and a half months postoperatively, a mass involving the inferior iris and ciliary body became visible, and fine-needle aspiration biopsy confirmed uveal melanoma. Seven weeks after diagnosis, the tumor\u2019s largest basal diameter had increased from 2.51 mm to 18.0 mm, and apical height increased from 6.23 mm to 11.0 mm. His right eye was enucleated. Histopathological analysis showed discontinuous invasion next to the Ahmed valve. Tumor progression after injection raises the possibility that in some untreated uveal melanomas, accelerated growth may occur following exposure to anti-VEGF agents.<\/jats:p>","DOI":"10.5693\/djo.02.2020.06.001","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T19:58:41Z","timestamp":1617911921000},"page":"27-30","source":"Crossref","is-referenced-by-count":4,"title":["Rapid growth of primary uveal melanoma following intravitreal bevacizumab injection: a case report and review of the literature"],"prefix":"10.5693","volume":"26","author":[{"given":"Jingyi","family":"Ma, BMSc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey A.","family":"Roelofs, MD, FRCSC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Russell, MD, FRCPC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezekiel","family":"Weis, MD, MPH, FRCSC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia H.","family":"Chen, MDCM, MBA, FRCSC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3822","published-online":{"date-parts":[[2020,7,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","unstructured":"1. Shields C, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol 2009;127:989-98.","journal-title":"Arch Ophthalmol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Amin M, Edge S, Greene F, et al. AJCC Cancer Staging Manual. 8th ed. New York: Springer, 2017.","DOI":"10.1007\/978-3-319-40618-3"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2015.11.019","article-title":"Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas","volume":"162","author":"Corr\u00eaa ZM","year":"2016","unstructured":"3. Corr\u00eaa ZM, Augsburger JJ. Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas. Am J Ophthalmol 2016;162:20-7.","journal-title":"Am J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S0161-6420(84)34088-X","article-title":"Growth rates and doubling times of posterior uveal melanomas","volume":"91","author":"Augsburger","year":"1984","unstructured":"4. Augsburger JJ, Gonder JR, Amsel J, et al. Growth rates and doubling times of posterior uveal melanomas. Ophthalmology 1984;91:1709-15.","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/archopht.1985.01050070050028","article-title":"Comparison of uveal melanoma growth rates with mitotic index and mortality","volume":"103","author":"Gass","year":"1985","unstructured":"5. Gass JDM. Comparison of uveal melanoma growth rates with mitotic index and mortality. Arch Ophthalmol 1985;103:924-31.","journal-title":"Arch Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0161-6420(87)33537-7","article-title":"Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors","volume":"94","author":"Shields","year":"1987","unstructured":"6. Shields CL, Shields JA, Shields MB, Augsburger JJ. Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology 1987;94:839-46.","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1001\/jamaophthalmol.2013.828","article-title":"Inadvertent implantation of aqueous tube shunts in glaucomatous eyes with unrecognized intraocular neoplasms: report of 5 cases","volume":"131","author":"Kaliki","year":"2013","unstructured":"7. Kaliki S, Eagle R, Grossniklaus H, Campbell RJ, Shields CL, Shields JA. Inadvertent implantation of aqueous tube shunts in glaucomatous eyes with unrecognized intraocular neoplasms: report of 5 cases. JAMA Ophthalmol 2013;131:925-8.","journal-title":"JAMA Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000441726","article-title":"Orbital extension of an unsuspected choroidal melanoma presumably through an aqueous tube shunt","volume":"2","author":"Kiratli","year":"2015","unstructured":"8. Kiratli H, Ko\u00e7 \u0130, Tarlan B. Orbital extension of an unsuspected choroidal melanoma presumably through an aqueous tube shunt. Ocul Oncol Pathol 2015;2:144-7.","journal-title":"Ocul Oncol Pathol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","unstructured":"9. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42.","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/archopht.124.10.1428","article-title":"Vascular endothelial growth factor a in eyes with uveal melanoma","volume":"124","author":"Missotten","year":"2006","unstructured":"10. Missotten G, Notting I, Schlingemann R, et al. Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428-34.","journal-title":"Arch Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1167\/iovs.09-4755","article-title":"Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma","volume":"51","author":"Yang","year":"2010","unstructured":"11. Yang H, Jager M, Grossniklaus H. Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma. Invest Ophthalmol Vis Sci 2010;51:2835-42.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","unstructured":"12. El Filali M, Ly LV, Luyten GPM, et al. Bevacizumab and intraocular tumors: an intriguing paradox. Mol Vis 2012;18:2454-67."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ajo.2010.08.040","article-title":"The impact of intravitreal bevacizumab therapy on choroidal melanoma","volume":"151","author":"Lima","year":"2011","unstructured":"13. Lima B, Schoenfield L, Singh A. The impact of intravitreal bevacizumab therapy on choroidal melanoma. Am J Ophthalmol 2011;151:323-8.","journal-title":"Am J Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000450859","article-title":"Growth of uveal melanoma following intravitreal bevacizumab","volume":"3","author":"Francis","year":"2016","unstructured":"14. Francis J, Kim J, Lin A, Folberg R, Iyer S, Abramson DH. Growth of uveal melanoma following intravitreal bevacizumab. Ocul Oncol Pathol 2016;3:117-21.","journal-title":"Ocul Oncol Pathol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12886-019-1108-z","article-title":"Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid","volume":"19","author":"Lee","year":"2019","unstructured":"15. Lee J, Kwon H, Kim M, Lee CS, Lee SC. Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid. BMC Ophthalmol 2019;19:103.","journal-title":"BMC Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00417-017-3834-3","article-title":"Invtravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy","volume":"256","author":"Mahdjoubi","year":"2018","unstructured":"16. Mahdjoubi A, Najean M, Lemaitre S, et al. Invtravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy. Graefes Arch Clin Exp Ophthalmol 2018;256:411-20.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1001\/archopht.1997.01100160184007","article-title":"Uveal melanoma: growth rate and prognosis","volume":"115","author":"Char","year":"1997","unstructured":"17. Char D, Kroll S, Phillips TL. Uveal melanoma: growth rate and prognosis. Arch Ophthalmol 1997;115:1014-8.","journal-title":"Arch Ophthalmol"}],"container-title":["Digital Journal of Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/djo.harvard.edu\/index.php\/djo\/article\/download\/75\/74","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/djo.harvard.edu\/index.php\/djo\/article\/download\/75\/74","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T15:47:44Z","timestamp":1680709664000},"score":1,"resource":{"primary":{"URL":"https:\/\/djo.harvard.edu\/index.php\/djo\/article\/view\/75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,3]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9,30]]}},"URL":"https:\/\/doi.org\/10.5693\/djo.02.2020.06.001","relation":{},"ISSN":["1542-8958"],"issn-type":[{"value":"1542-8958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,3]]}}}